25534388Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HMJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Prostatic Neoplasms; RadiotherapyAged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chemoradiotherapy; Disease-Free Survival; Flutamide; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Time Factors; Tosyl Compounds; Treatment OutcomeDuration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol. 2015 Feb 01; 33(4):332-9.J Clin Oncol2014-12-22T00:00:002014Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD000726Chemicals & DrugsPhysiology411400.907129Androgen AntagonistsD005485Chemicals & Drugs340.999148FlutamideD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD009570Chemicals & Drugs791450.946316NitrilesD009367Concepts & IdeasProcedures34719320.670065Neoplasm StagingD011471Disorders23517080.438658Prostatic NeoplasmsD014105Chemicals & Drugs11140.993668Tosyl CompoundsD011878Procedures1213260.839686RadiotherapyD006801Living Beings2262862810.130052HumansD013997Concepts & Ideas118351980.519628Time FactorsD008297Physiology1931408600.201617MaleD017430Chemicals & Drugs953460.825491Prostate-Specific AntigenD016896Concepts & Ideas101179490.402389Treatment OutcomeD018931Chemicals & Drugs631500.911763Antineoplastic Agents, HormonalD059248Procedures943010.814259ChemoradiotherapyPublic Health SciencesD016729Chemicals & Drugs17300.9846LeuprolideD017273Chemicals & Drugs560.996751GoserelinD060787Concepts & IdeasProcedures1433560.874575Neoplasm GradingD000813Chemicals & Drugs28460.961578AnilidesD005500Procedures76836160.590107Follow-Up StudiesD018572Concepts & Ideas25812030.792696Disease-Free SurvivalUniversity of ChicagoJames J.DignamJames J. Dignam41.78927490000000-87.601250000000001491Dignam, James J.Professortrue1ProfessorProfessorAuthorship 67521150.1315340.1315341authors10.2524has subject area